Back to News
Market Impact: 0.08

Texas Cardiac Arrhythmia Institute pri St. David's Medical Center sa zúčastňuje na skúšaní inovatívneho mapovacieho a pulzného ablačného systému ako prvý v USA

Source: PR Newswire

Healthcare & BiotechTechnology & Innovation

Texas Cardiac Arrhythmia Institute (TCAI) at St. David's Medical Center announced it became the first site in the country to participate in a clinical trial evaluating the safety and efficacy of a mapping and pulsed ablation system. The release is primarily institutional/clinical trial participation news without reported outcomes, financial figures, or broader market implications.

AllMind Terminal

AI-powered research, real-time alerts, and portfolio analytics for institutional investors.

Request Trial

Market Sentiment

Overall Sentiment

neutral

Sentiment Score

0.05

More News

From AllMind Research

Browse all research